LENSAR, Inc. LNSR
5.56 USD -0.29 (-4.88%)
Nov 5, 2026, 12:24 PM EST
5.60 Day range 5.95
4.95 52-week range 12.94
- YTD
- -52.24%
- 1 year
- -54.32%
News
globenewswire.com LENSAR® to Report Third Quarter 2026 Results on November 10th, 2026 ORLANDO, Fla., Nov. 03, 2026 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”), a global medical technology company focused on advanced robotic laser solutions for the…
seekingalpha.com Cedar Grove Capital Q3 2026 Portfolio Update During the quarter, we closed our long positions in MTY Food Group, uniQure, ClearPoint Neuro, and Suja Life Inc. During the quarter, we closed short positions in Bending Spoons SpA, Chipotle Mexican…
benzinga.com LUCID CAPITAL MARKETS Initiates Coverage On LENSAR with Buy Rating, Announces Price Target of $11 LUCID CAPITAL MARKETS analyst Alex Nowark initiates coverage on LENSAR (NASDAQ:LNSR) with a Buy rating and announces Price Target of $11.
benzinga.com BTIG Maintains Buy on LENSAR, Raises Price Target to $10 BTIG analyst Ryan Zimmerman maintains LENSAR (NASDAQ:LNSR) with a Buy and raises the price target from $9 to $10.
marketbeat.com LENSAR Q2 Earnings Call Highlights LENSAR NASDAQ: LNSR reported second-quarter 2026 revenue growth of 18% as the company continued to rebuild commercial momentum following the termination of its proposed merger with Alcon near the end…
benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session Gainers Liminatus Pharma (NASDAQ:LIMN) stock increased by 48.4% to $0.16 during Thursday's regular session. The market value of their outstanding shares is at $7.2 million. BeyondSpring (NASDAQ:BYSI)…
seekingalpha.com LENSAR, Inc. (LNSR) Q2 2026 Earnings Call Transcript LENSAR, Inc. (LNSR) Q2 2026 Earnings Call Transcript- benzinga.com LENSAR Q2 2026 Earnings Call: Complete Transcript LENSAR (NASDAQ:LNSR) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below. This content is powered by Benzinga…
benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session Gainers Liminatus Pharma (NASDAQ:LIMN) stock moved upwards by 55.9% to $0.17 during Thursday's pre-market session. The company's market cap stands at $7.2 million. LENSAR (NASDAQ:LNSR) shares…
benzinga.com LENSAR Q2 EPS $0.10 Beats $(0.17) Estimate, Sales $16.495M Beat $14.650M Estimate LENSAR (NASDAQ:LNSR) reported quarterly earnings of $0.10 per share which beat the analyst consensus estimate of $(0.17) by 162.5 percent. This is a 166.67 percent increase over losses of $(0.15) per…
globenewswire.com LENSAR® Reports Second Quarter 2026 Results and Provides Business Update 10 ALLY Robotic Cataract Laser Systems® (“ALLY System”) Placements in Second Quarter 2026; Backlog of 13 ALLY Systems as of June 30, 2026 Second Quarter Recurring Revenue was $13.7 million Total…
defenseworld.net LENSAR Shareholders Re-Elect Directors, Back Executive Pay at 2026 Annual Meeting LENSAR (NASDAQ: LNSR) shareholders elected three Class III directors, ratified the appointment of PricewaterhouseCoopers LLP as the company's independent auditor and approved advisory proposals on…
benzinga.com Lensar Appoints Michael A. Rossi As Interim CFO Effective May 29, 2026 On May 25, 2026, the Board of Directors (the "Board") of LENSAR, Inc. (the "Company") appointed Michael A. Rossi to serve as the Company's Interim Chief Financial Officer and principal financial…
marketbeat.com LENSAR Q1 Earnings Call Highlights LENSAR NASDAQ: LNSR executives told investors on Thursday that the company is moving past a “transaction-related holding pattern” after the termination of its planned merger, and is now refocusing on…
seekingalpha.com LENSAR, Inc. (LNSR) Q1 2026 Earnings Call Transcript LENSAR, Inc. (LNSR) Q1 2026 Earnings Call Transcript
benzinga.com LENSAR Q1 Sales $13.428M Miss $13.450M Estimate LENSAR (NASDAQ:LNSR) reported quarterly sales of $13.428 million which missed the analyst consensus estimate of $13.450 million by 0.16 percent. This is a 5.16 percent decrease over sales of $14.159…
globenewswire.com LENSAR® Reports First Quarter 2026 Results and Provides Business Update 7 ALLY Robotic Cataract Laser Systems® (“ALLY System”) Placements in First Quarter 2026; Backlog of 11 ALLY Systems as of March 31, 2026
globenewswire.com LENSAR® to Report First Quarter 2026 Results on May 8, 2026 ORLANDO, Fla., April 30, 2026 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”), a global medical technology company focused on advanced robotic laser solutions for the…
defenseworld.net Head-To-Head Review: LENSAR (NASDAQ:LNSR) vs. Edwards Lifesciences (NYSE:EW) LENSAR (NASDAQ: LNSR - Get Free Report) and Edwards Lifesciences (NYSE: EW - Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based on…
seekingalpha.com LENSAR, Inc. (LNSR) Q4 2025 Earnings Call Transcript LENSAR, Inc. (LNSR) Q4 2025 Earnings Call Transcript
benzinga.com Earnings Scheduled For March 31, 2026 
globenewswire.com LENSAR® Reports Fourth Quarter and Full Year 2025 Results and Provides Business Update 15 ALLY Robotic Cataract Laser Systems® (“ALLY Systems”) placed in 4Q 2025; Backlog of 13 ALLY Systems pending installation as of December 31, 2025
defenseworld.net Contrasting DexCom (NASDAQ:DXCM) and LENSAR (NASDAQ:LNSR) DexCom (NASDAQ: DXCM - Get Free Report) and LENSAR (NASDAQ: LNSR - Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the…
benzinga.com This Block Analyst Is No Longer Bearish; Here Are Top 4 Upgrades For Wednesday Top Wall Street analysts changed outlook on top names. See analyst ratings for upgrades, downgrades & initiations on our page. Check XYZ stock.- benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session
benzinga.com Crude Oil Gains Around 2%; Elbit Systems Shares Jump On Upbeat Earnings US stocks rose, with Dow Jones up 0.39% & NASDAQ up 0.59%. Energy shares jumped 1.7%, while industrials fell 0.1%. Elbit Systems shares up 10%.
benzinga.com Why Playboy Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket Playboy (PLBY) shares rise in pre-market trading after reporting better-than-expected Q4 results. Other gainers include PTOR, LNAI, LIDR, ISPC, WNW, JVA, NUAI, XLO, and BW. Losers include PRSO, DFLI,…
benzinga.com Nasdaq Surges Over 100 Points; Academy Sports And Outdoors Posts Downbeat Earnings US stocks started higher this morning, with NASDAQ up over 100 points. Energy shares rose by 1.3%, while Aldeyra and Meiwu Tech saw sharp declines.
benzinga.com LENSAR Stock Plunges—Alcon Scraps Merger After Prolonged Regulatory Review In March 2025, Alcon agreed to acquire the laser solutions company for $14.00 per share for an aggregate implied value of approximately $356 million.
gurufocus.com BYND And LNSR Set The Tone Tuesday Beyond Meat (BYND) and LENSAR (LNSR) are among the names driving early action Tuesday as stock futures edge lower and oil prices move higher amid ongoing Iran r
benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session - benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session
globenewswire.com LENSAR® Announces Termination of Merger Agreement with Alcon Research, LLC ORLANDO, Fla., March 16, 2026 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”), a global medical technology company focused on advanced robotic laser solutions for the…
globenewswire.com LENSAR® Provides Update on Pending Acquisition by Alcon ORLANDO, Fla., Feb. 25, 2026 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”), a global medical technology company focused on advanced robotic laser solutions for the…
defenseworld.net Credit Industriel ET Commercial Sells 45,117 Shares of LENSAR, Inc. $LNSR Credit Industriel ET Commercial reduced its position in shares of LENSAR, Inc. (NASDAQ: LNSR) by 26.8% during the undefined quarter, according to the company in its most recent Form 13F filing with…
defenseworld.net Head to Head Analysis: LENSAR (NASDAQ:LNSR) versus enVVeno Medical (NASDAQ:NVNO) LENSAR (NASDAQ: LNSR - Get Free Report) and enVVeno Medical (NASDAQ: NVNO - Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two…
benzinga.com Earnings Scheduled For February 27, 2025 
benzinga.com Earnings Scheduled For March 4, 2024 Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is estimated to report earnings for its fourth quarter.- benzinga.com Earnings Scheduled For November 9, 2023 Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is expected to report quarterly earnings at $0.30 per share on revenue of $265.00 million.
- benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- benzinga.com Earnings Scheduled For August 9, 2023 Companies Reporting Before The Bell • Sony Group (NYSE:SONY) is estimated to report quarterly earnings at $0.96 per share on revenue of $18.11 billion.
benzinga.com Earnings Scheduled For May 15, 2023 Companies Reporting Before The Bell • Caledonia Mining (AMEX:CMCL) is expected to report earnings for its first quarter. • Sohu.com (NASDAQ:SOHU) is projected to report earnings for its first quarter.- benzinga.com Stocks That Hit 52-Week Lows On Thursday On Thursday, 175 stocks hit new 52-week lows.
benzinga.com Earnings Scheduled For March 16, 2023 Companies Reporting Before The Bell • KVH Industries (NASDAQ:KVHI) is projected to report quarterly earnings at $0.03 per share on revenue of $34.29 million.
benzinga.com Stocks That Hit 52-Week Lows On Wednesday On Wednesday, 258 companies hit new 52-week lows.- benzinga.com Stocks That Hit 52-Week Lows On Friday OnFriday, 143 stocks hit new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Thursday Thursday's session saw 329 companies set new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Wednesday During Wednesday's session, 107 stocks hit new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Monday On Monday, 79 companies reached new 52-week lows.
- benzinga.com Why Drive Shack Shares Jumped Over 23%; Here Are 76 Biggest Movers From Yesterday Gainers Imago BioSciences, Inc. (NASDAQ: IMGO) shares climbed 104.5% to close at $35.59 on Monday after Merck announced it would acquire the company for $36 per share in cash.